Search tool

This is the DRD-Standard, the current protocol for the EMCDDA's drug-related deaths (DRD) indicator, one of five key epidemiological indicators used by the EMCDDA for the collection and interpretaion of harmonised, good...

The General report of activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its...

Trends in injecting drug use in Europe is the title of the latest EMCDDA Selected issue publication. This volume brings together data from a wide variety of sources as it describes Europe’s...

Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the Agency's activities to a broad readership. In this issue: record number of new drugs in 2009; EMCDDA and ECDC assess anthrax...

This report presents the results and outlines the key achievements and challenges faced by mechanism set up by the Council Decision in 2009. In 2009, 24 new psychoactive substances were officially notified...

Prices are an essential element of the illicit drug market, from both a supply and demand perspective. They are an indicator of drug availability and are an important tool for understanding the...

In January 2010, increased evidence of the availability and use of mephedrone (4- methylmethcathinone) prompted the EMCDDA and Europol to launch a procedure for the production of a Joint Report. Pursuant to...

The 2010 work programme is the first to fall under the EMCDDA’s new three-year strategy and work programme (2010–12). In terms of substantive technical activities, the three-year strategy aims to consolidate the...

Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the Agency's activities to a broad readership. In this issue: 2010 work programme and budget; EMCDDA and Europol step up information collection...

This country overview provides a structured synopsis of the trends and characteristics of national drug problems in Albania in 2009. It consists of a summary of the national drug situation presenting brief...